Comments
EU agency rejects Sanofi, Isis cholesterol drug
15.12.2012. | LONDON (Reuters) - European regulators recommended against approval of Sanofi and Isis Pharmaceutical's Kynamro drug for treatment of a rare genetic disorder that causes unusually high cholesterol....
